Alnylam Pharmaceuticals
Develops RNAi therapeutics to treat rare and common diseases.
H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
biotechpharmaceuticals
Company facts
- Founded
- 2002
- Employees
- 2,500
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: ALNY
Open positions
6 jobs
5 views 2 days ago
Senior Director, Head of PV Science
Open 50d HybridNorth AmericaFull-timeC-level H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
United States
Cambridge, MA or Philadelphia, PAOverview Alnylam is the industry leader in the translation of RNA interference (RNAi) into a new class of innovative medicines with the potential to address the unmet needs of patients with debilitating diseases.…
AI Analytics Corrective Action Process Improvement